Interviews /
by Finance News Network -
A year ago
16 Aug 2023 - Dr John Melki - CEO and Director - Genetic Signatures (ASX:GSS) is transforming molecular diagnostics via streamlined sample processing methods linked to highly multi…
Company News /
by Peter Milios -
A year ago
26 Jul 2023 - Whilst the prevalence of Artificial intelligence has boosted the US tech sector, Australian tech stock valuations have largely been dampened amid rising interest rate…
Company Presentations /
by Finance News Network -
A year ago
12 Dec 2022 - John Melki - CEO and Director - Genetic Signatures is a specialist molecular diagnostics (MDx) company focused on the development and commercialisation of its proprie…
Interviews /
by Lauren Hayes -
A year ago
17 Nov 2022 - Genetic Signatures Limited (ASX:GSS) CEO and Director Dr John Melki discusses the company's technology, business model, 2022 highlights and outlook.
Company News /
by Rachael Jones -
4 years ago
14 Apr 2020 - Genetic Signatures (ASX:GSS) has received notice from the Therapeutic Goods Administration (“TGA”) that its EasyScreenTM SARS-CoV-2 Detection Kit has been approved to…
Company News /
by -
9 years ago
15 Sep 2015 - Genetic Signatures Limited (ASX:GSS) announces a new appointment to the Board of Directors.
Market Reports /
by -
9 years ago
31 Mar 2015 - Aus shares stay positive. Blackmores Limited (ASX:BKL) announces continued strong sales growth for the third quarter of the 2015 financial year.
